Full Breakdown
Colossal Biosciences Hatches Chickens in 3-D-Printed “Artificial Egg” – A Step Toward Moa De-Extinction
5/22/2026, 12:08:58 AM
Core Breakthrough: 26 Chickens Hatched in a Synthetic Egg
On 19 May 2026, Dallas-based biotech firm Colossal Biosciences announced that its artificial egg—a 3-D-printed titanium lattice with a silicone-based membrane—successfully hatched 26 healthy chickens. Fertilized chicken embryos were transferred from real eggs into the device, incubated under standard conditions, and monitored through a transparent window until hatching. The company frames the result as a proof-of-concept for future resurrection of extinct birds such as New Zealand’s South Island giant moa.
Background & Context: From Shell-Less Experiments to De-Extinction Ambitions
Artificial-egg systems have existed since the 1980s but suffered low hatch rates because they required supplemental oxygen that damaged DNA. Colossal’s design claims passive gas exchange comparable to a natural shell, eliminating the need for high-oxygen environments. The firm’s broader de-extinction portfolio already includes genome-edited dire-wolf pups (2024) and ongoing projects targeting the dodo, woolly mammoth, and thylacine.
Key Figures & Groups
- Ben Lamm – CEO & co-founder, Colossal Biosciences
- Andrew Pask – Chief Biology Officer, Colossal
- Beth Shapiro – Chief Science Officer, Colossal
- George Church – Co-founder, Harvard Medical School
- Vincent Lynch – Evolutionary biologist, University at Buffalo (critic)
- Arthur Caplan – Bioethicist, NYU Grossman School of Medicine (critic)
- Carles Lalueza-Fox – Director, Museum of Natural Sciences of Barcelona (critic)
- Jeanne Loring – Biologist, Scripps Institute (critic)
- Peter Dearden – Professor of Genetics, University of Otago (critic)
- Nic Rawlence – Associate professor, University of Otago (supportive)
Data & Statistics
- 26 chicks hatched; hatch-rate not disclosed.
- Artificial membrane provides ? 21 % oxygen transfer capacity, exceeding that of a natural chicken shell.
- Moa eggs were ? 80 × the volume of a chicken egg and ? 8 × an emu egg, precluding any living surrogate.
- The device’s lattice is hexagonal; the silicone membrane is semi-permeable, allowing CO2 outflow and O2 inflow while retaining moisture.
Official Statements & Responses
Colossal’s leadership described the platform as “fully scalable and biologically accurate,” emphasizing that it replicates the gas-exchange, humidity, and mechanical environment of a natural egg at any size. Ben Lamm said the company is “building something nature already does well, but better and more efficient,” and that the 26 chickens will “live out their natural lives” while the team prepares larger-scale versions for pigeon, emu, and eventually moa embryos. Andrew Pask highlighted the membrane as “a really specialized very thin membrane that enables effective gas exchange.” Beth Shapiro framed the artificial egg as “the missing piece” for species where surrogacy is impossible, noting that “the genome is the blueprint, but without a place to build, it’s meaningless.” George Church added that the system “solves the scalability dimension” and can be adapted to any avian size.
Criticism & Opposition
Scientists questioned both feasibility and ethics. Vincent Lynch warned that the technology would only produce a “genetically modified bird, not a moa.” Arthur Caplan asked, “What environment is this animal going to live in?” Carles Lalueza-Fox called the ecological relevance “legitimate to ask” and doubted the fate of such engineered birds. Jeanne Loring warned that resurrecting extinct forms “could be very cruel” and “catastrophic.” Peter Dearden labeled the goal “impossible,” noting the extinct lineage of the moa. Amanda Black criticized the company’s “cosplaying conservationists” while acknowledging the technical advance.
Conflicting Reports & Gaps
Colossal released no peer-reviewed paper or raw data, preventing independent validation. The hatch-rate for the 26 chicks remains undisclosed, limiting comparison with prior shell-less methods. Experts disagree on whether the artificial egg alone can overcome the biological challenges of scaling to moa-size embryos, and no consensus exists on the ecological viability of resurrected birds.
Verbatim Quotes
- “They might be able to use this technology to help them make a genetically modified bird, but that’s just a genetically modified bird. It’s not a moa,” — Vincent Lynch, Evolutionary Biologist, University at Buffalo
- “The big challenge is, what environment is this animal going to live in?” — Arthur Caplan, Bioethicist, NYU Grossman School of Medicine
- “It is legitimate to ask whether it makes ecological sense to genetically redesign some modern birds to superficially resemble moas, and what fate would await such animals,” — Carles Lalueza-Fox, Director, Museum of Natural Sciences of Barcelona
- “It could be very cruel to those animals,” — Jeanne Loring, Biologist, Scripps Institute
- “So before we get to the egg itself, let’s be clear that this is, in my opinion, impossible” — Peter Dearden, Professor of Genetics, University of Otago
- “Credit where credit is due, this is really impressive work that could result in a new tool in the conservation toolbox in the future” — Nic Rawlence, Associate Professor, University of Otago
Why It Matters / Impact
If scalable, the artificial egg could enable embryo development for species lacking viable surrogates, opening pathways for both de-extinction (moa, dodo) and conservation of critically endangered birds (kakapo, kaki). Proponents argue it offers a “platform technology” for genome-edited avian rescue, while detractors caution that it may divert funding from habitat protection and risk creating animals ill-suited to modern ecosystems.
What’s Next
Colossal plans to test the system with smaller pigeon eggs and larger emu eggs, aiming to produce a size-adjustable platform by the early-mid 2030s. The company envisions self-hatching lattices and robotic embryo transfer to reduce variability. Success with the moa would require a surrogate species for early development, extensive genome editing, and a viable habitat in New Zealand—milestones the firm acknowledges remain “a long road ahead.”
